Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)
This study has been completed.
Study NCT00109382 Information provided by University of Calgary
First Received on April 27, 2005. Last Updated on April 7, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Transient Ischemic Attack
Stroke
Additional conditions recognized in this trial
Cerebral Infarction
Ischemia
Ischemic Attack, Transient
Recurrence
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Disease Attributes
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Aspirin
Clopidogrel
Simvastatin
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anticholesteremic Agents
Antimetabolites
Antipyretics
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Purinergic Agents
Purinergic Antagonists
Purinergic P2 Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of Calgary
Canadian Institutes of Health Research (CIHR)
Canadian Stroke Consortium (CSC)
Back to top of Main Content
